Peter Openshaw

52PUBLICATIONS
378CO-AUTHORS
Predictive and prognostic markersInnate immunityRespiratory diseasesBioinformatic methods developmentCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Oct 11, 2026
Sputum and oral microbiota profiles are associated with long COVID severity and phenotype post-hospitalisation: a UK multicentre, prospective cohort study.

|Dec 07, 2025
Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infection.

Helen R Wagstaffe, Ryan S Thwaites, Jasmin K Sidhu

|Oct 29, 2025
Hypoxia induces histone clipping and H3K4me3 loss in neutrophil progenitors resulting in long-term impairment of neutrophil immunity.

Manuel A Sanchez-Garcia, Pranvera Sadiku, Brian M Ortmann

|Apr 23, 2025
Human challenge models for vaccine development-strengths, limitations, and expansion into endemic settings: a HIC-Vac meeting report.

Helen R Wagstaffe, Stephanie Ascough, Peter J M Openshaw

|Apr 15, 2025
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development.

E Z Siegal, J M H Schoevers, J Terstappen

|Oct 09, 2024
Antibody-mediated protection against respiratory syncytial virus in children.

Emma L Coindy, Claudia Efstathiou, Shubha Talwar

Pageof 9

Frequent Collaborators

22 joint publications

Malcolm G Semple

19 joint publications

Kenneth Baillie

15 joint publications

Ryan Thwaites

8 joint publications

Lance Turtle